Bradley Thompson

Bradley George Thompson is the founder of Oncolytics Biotech, Inc. which was founded in 1999.
He held the titles of Co-Chairman, President & Chief Executive Officer from 1999 to 2016.
Currently, he is the Chief Executive Officer at Kickshaw Ventures Ltd.
and holds the title of Chief Executive Officer at Wyvern Pharmaceuticals, Inc., Avamab Pharma, Inc., and Chairman & Chief Technology Officer at Cellastra, Inc. He is also an Independent Director at Zenith Capital Corp.
(Alberta) since 2022.
Dr. Thompson's former jobs include Chief Executive Officer at Hawker Resources, Inc. from 1994 to 1999, Chief Executive Officer at Iteration Energy Ltd.
in 1999, Chairman at BIOTECanada, Independent Director at Aptose Biosciences, Inc. from 2013 to 2018, Director at E3 Lithium Ltd., Reviva Pharmaceuticals, Inc., IMV, Inc., and MagicMed Industries, Inc. He was also an Independent Director at Enveric Biosciences, Inc. from 2021 to 2022.
Dr. Thompson received his undergraduate degree from the University of Alberta and his doctorate degree from the University of Western Ontario.